These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advancement of platelet-inspired nanomedicine. Wang S; Yuan J; Yang J; Li N; Liu R; Luan J; Ye D Platelets; 2018 Nov; 29(7):690-694. PubMed ID: 29883255 [TBL] [Abstract][Full Text] [Related]
4. Beyond the thrombus: Platelet-inspired nanomedicine approaches in inflammation, immune response, and cancer. Desai C; Koupenova M; Machlus KR; Sen Gupta A J Thromb Haemost; 2022 Jul; 20(7):1523-1534. PubMed ID: 35441793 [TBL] [Abstract][Full Text] [Related]
5. Procoagulant platelets: novel players in thromboinflammation. Denorme F; Campbell RA Am J Physiol Cell Physiol; 2022 Oct; 323(4):C951-C958. PubMed ID: 35993516 [TBL] [Abstract][Full Text] [Related]
6. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765 [TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice. Shukla M; Sekhon UD; Betapudi V; Li W; Hickman DA; Pawlowski CL; Dyer MR; Neal MD; McCrae KR; Sen Gupta A J Thromb Haemost; 2017 Feb; 15(2):375-387. PubMed ID: 27925685 [TBL] [Abstract][Full Text] [Related]
8. Platelet-Inspired Intravenous Nanomedicine for Injury-Targeted Direct Delivery of Thrombin to Augment Hemostasis in Coagulopathies. Girish A; Jolly K; Alsaadi N; de la Fuente M; Recchione A; An R; Disharoon D; Secunda Z; Raghunathan S; Luc NF; Desai C; Knauss E; Han X; Hu K; Wang H; Sekhon UDS; Rohner N; Gurkan UA; Nieman M; Neal MD; Sen Gupta A ACS Nano; 2022 Oct; 16(10):16292-16313. PubMed ID: 35916497 [TBL] [Abstract][Full Text] [Related]
9. TMEM16F-Mediated Platelet Membrane Phospholipid Scrambling Is Critical for Hemostasis and Thrombosis but not Thromboinflammation in Mice-Brief Report. Baig AA; Haining EJ; Geuss E; Beck S; Swieringa F; Wanitchakool P; Schuhmann MK; Stegner D; Kunzelmann K; Kleinschnitz C; Heemskerk JW; Braun A; Nieswandt B Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2152-2157. PubMed ID: 27634832 [TBL] [Abstract][Full Text] [Related]
10. Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation. Mandel J; Casari M; Stepanyan M; Martyanov A; Deppermann C Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409226 [TBL] [Abstract][Full Text] [Related]
12. A platelet-inspired paradigm for nanomedicine targeted to multiple diseases. Modery-Pawlowski CL; Kuo HH; Baldwin WM; Sen Gupta A Nanomedicine (Lond); 2013 Oct; 8(10):1709-27. PubMed ID: 24074391 [TBL] [Abstract][Full Text] [Related]
13. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis. Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136 [TBL] [Abstract][Full Text] [Related]
14. Cancer-associated-platelet-inspired nanomedicines for cancer therapy. Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125 [TBL] [Abstract][Full Text] [Related]
15. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms. Marin Oyarzún CP; Heller PG Front Immunol; 2019; 10():1373. PubMed ID: 31258539 [TBL] [Abstract][Full Text] [Related]
16. Platelet toll-like receptors in thromboinflammation. D' Atri LP; Schattner M Front Biosci (Landmark Ed); 2017 Jun; 22(11):1867-1883. PubMed ID: 28410150 [TBL] [Abstract][Full Text] [Related]
17. Why platelet mechanotransduction matters for hemostasis and thrombosis. Oshinowo O; Azer SS; Lin J; Lam WA J Thromb Haemost; 2023 Sep; 21(9):2339-2353. PubMed ID: 37331517 [TBL] [Abstract][Full Text] [Related]
18. Platelets in thrombosis and hemostasis: old topic with new mechanisms. Wang Y; Andrews M; Yang Y; Lang S; Jin JW; Cameron-Vendrig A; Zhu G; Reheman A; Ni H Cardiovasc Hematol Disord Drug Targets; 2012 Dec; 12(2):126-32. PubMed ID: 23030445 [TBL] [Abstract][Full Text] [Related]
19. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis. Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149 [TBL] [Abstract][Full Text] [Related]
20. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease. Kaur H; Corscadden K; Ware J; Othman M Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]